MedTrace Logo

Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis

NCT01659827 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2013-12-11

No results posted yet for this study

Summary

The purpose of this study is to determine whether the AmnioFix Injectable human amniotic membrane is effective in the treatment of recalcitrant plantar fasciitis.

Conditions

  • Plantar Fasciitis

Interventions

OTHER

Marcaine

Injection of 2cc of Marcaine

OTHER

0.5cc AmnioFix

Injection of 0.5cc of AmnioFix Injectable

OTHER

1.25cc AmnioFix

Injection of 1.25cc of AmnioFix Injectable

OTHER

Saline

Injection of 1.25cc of Saline

Sponsors & Collaborators

  • MiMedx Group, Inc.

    lead INDUSTRY

Principal Investigators

  • Charles M. Zelen, DPM · Professional Education and Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01659827 on ClinicalTrials.gov